258 related articles for article (PubMed ID: 12857950)
41. Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex.
Matilla A; Gorbea C; Einum DD; Townsend J; Michalik A; van Broeckhoven C; Jensen CC; Murphy KJ; Ptácek LJ; Fu YH
Hum Mol Genet; 2001 Nov; 10(24):2821-31. PubMed ID: 11734547
[TBL] [Abstract][Full Text] [Related]
42. Aggregation of polyglutamine-expanded ataxin-3 sequesters its specific interacting partners into inclusions: implication in a loss-of-function pathology.
Yang H; Li JJ; Liu S; Zhao J; Jiang YJ; Song AX; Hu HY
Sci Rep; 2014 Sep; 4():6410. PubMed ID: 25231079
[TBL] [Abstract][Full Text] [Related]
43. Structure of the ubiquitin-interacting motif of S5a bound to the ubiquitin-like domain of HR23B.
Fujiwara K; Tenno T; Sugasawa K; Jee JG; Ohki I; Kojima C; Tochio H; Hiroaki H; Hanaoka F; Shirakawa M
J Biol Chem; 2004 Feb; 279(6):4760-7. PubMed ID: 14585839
[TBL] [Abstract][Full Text] [Related]
44. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation.
Bowman AB; Yoo SY; Dantuma NP; Zoghbi HY
Hum Mol Genet; 2005 Mar; 14(5):679-91. PubMed ID: 15661755
[TBL] [Abstract][Full Text] [Related]
45. Ruk is ubiquitinated but not degraded by the proteasome.
Verdier F; Valovka T; Zhyvoloup A; Drobot LB; Buchman V; Waterfield M; Gout I
Eur J Biochem; 2002 Jul; 269(14):3402-8. PubMed ID: 12135478
[TBL] [Abstract][Full Text] [Related]
46. Cellular turnover of the polyglutamine disease protein ataxin-3 is regulated by its catalytic activity.
Todi SV; Laco MN; Winborn BJ; Travis SM; Wen HM; Paulson HL
J Biol Chem; 2007 Oct; 282(40):29348-58. PubMed ID: 17693639
[TBL] [Abstract][Full Text] [Related]
47. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.
Cummings CJ; Reinstein E; Sun Y; Antalffy B; Jiang Y; Ciechanover A; Orr HT; Beaudet AL; Zoghbi HY
Neuron; 1999 Dec; 24(4):879-92. PubMed ID: 10624951
[TBL] [Abstract][Full Text] [Related]
48. Vps27-Hse1 and ESCRT-I complexes cooperate to increase efficiency of sorting ubiquitinated proteins at the endosome.
Bilodeau PS; Winistorfer SC; Kearney WR; Robertson AD; Piper RC
J Cell Biol; 2003 Oct; 163(2):237-43. PubMed ID: 14581452
[TBL] [Abstract][Full Text] [Related]
49. [Neurodegenerative diseases regulated by ubiquitin-proteasome system].
Hatakeyama S
Rinsho Shinkeigaku; 2006 Nov; 46(11):890-2. PubMed ID: 17432211
[TBL] [Abstract][Full Text] [Related]
50. Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes.
Jana NR; Dikshit P; Goswami A; Kotliarova S; Murata S; Tanaka K; Nukina N
J Biol Chem; 2005 Mar; 280(12):11635-40. PubMed ID: 15664989
[TBL] [Abstract][Full Text] [Related]
51. Genome-wide screen for modifiers of ataxin-3 neurodegeneration in Drosophila.
Bilen J; Bonini NM
PLoS Genet; 2007 Oct; 3(10):1950-64. PubMed ID: 17953484
[TBL] [Abstract][Full Text] [Related]
52. Polyglutamine-mediated aggregation and cell death.
de Cristofaro T; Affaitati A; Feliciello A; Avvedimento EV; Varrone S
Biochem Biophys Res Commun; 2000 Jun; 272(3):816-21. PubMed ID: 10860836
[TBL] [Abstract][Full Text] [Related]
53. N-Terminally extended human ubiquitin-conjugating enzymes (E2s) mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8.
Ito K; Adachi S; Iwakami R; Yasuda H; Muto Y; Seki N; Okano Y
Eur J Biochem; 2001 May; 268(9):2725-32. PubMed ID: 11322894
[TBL] [Abstract][Full Text] [Related]
54. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.
Parkinson J; Everett RD
J Virol; 2000 Nov; 74(21):10006-17. PubMed ID: 11024129
[TBL] [Abstract][Full Text] [Related]
55. Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo.
Hernández F; Díaz-Hernández M; Avila J; Lucas JJ
Trends Neurosci; 2004 Feb; 27(2):66-9. PubMed ID: 15106649
[TBL] [Abstract][Full Text] [Related]
56. Live-cell imaging reveals divergent intracellular dynamics of polyglutamine disease proteins and supports a sequestration model of pathogenesis.
Chai Y; Shao J; Miller VM; Williams A; Paulson HL
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9310-5. PubMed ID: 12084819
[TBL] [Abstract][Full Text] [Related]
57. NEDD8: a new ataxin-3 interactor.
Ferro A; Carvalho AL; Teixeira-Castro A; Almeida C; Tomé RJ; Cortes L; Rodrigues AJ; Logarinho E; Sequeiros J; Macedo-Ribeiro S; Maciel P
Biochim Biophys Acta; 2007 Nov; 1773(11):1619-27. PubMed ID: 17935801
[TBL] [Abstract][Full Text] [Related]
58. An arginine/lysine-rich motif is crucial for VCP/p97-mediated modulation of ataxin-3 fibrillogenesis.
Boeddrich A; Gaumer S; Haacke A; Tzvetkov N; Albrecht M; Evert BO; Müller EC; Lurz R; Breuer P; Schugardt N; Plassmann S; Xu K; Warrick JM; Suopanki J; Wüllner U; Frank R; Hartl UF; Bonini NM; Wanker EE
EMBO J; 2006 Apr; 25(7):1547-58. PubMed ID: 16525503
[TBL] [Abstract][Full Text] [Related]
59. Topors functions as an E3 ubiquitin ligase with specific E2 enzymes and ubiquitinates p53.
Rajendra R; Malegaonkar D; Pungaliya P; Marshall H; Rasheed Z; Brownell J; Liu LF; Lutzker S; Saleem A; Rubin EH
J Biol Chem; 2004 Aug; 279(35):36440-4. PubMed ID: 15247280
[TBL] [Abstract][Full Text] [Related]
60. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation.
Bennett EJ; Bence NF; Jayakumar R; Kopito RR
Mol Cell; 2005 Feb; 17(3):351-65. PubMed ID: 15694337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]